Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Recap: Bill would gut Kansas Bioscience Authority
A bill in the Kansas legislature if passed would dissolve the Kansas Bioscience Authority, which has recently served as a venture capital organization investing in early-stage bioscience firms. The measure — SB 305 — would shut down the organization and transfer its funds and obligations to the Kansas Department of Commence. Proponents of the KBA say…
Kansas City named a top tech locale
Kansas City again was touted as a top tech destination. Tech publication PC Magazine recently named Kansas City as one of “13 high-tech cities you’ll want to call home.” The magazine noted Kansas City’s access to Google Fiber, its low cost of living and communities such as the Kansas City Startup Village as reasons to…
Flow Forward Medical raises additional $1.3M
Flow Forward Medical boosted its latest funding round to further develop its device that helps improve outcomes for hemodialysis patients. The Olathe-based company closed a $1.3 million round of additional Series A financing led by the Kansas Bioscience Authority. Flow Forward previously raised $4.4 million, bringing its total funding raised to date to about $5.7 million.…
Schukman: 5 reasons why KC is the capital of social entrepreneurship
Take a walk in Kansas City’s startup scene and you’ll quickly hear something about KC’s devotion to becoming America’s most entrepreneurial city. This mantra is on everyone’s lips, from city leaders to corporate tycoons to scrappy startup founders. It’s amazing that in five years our city has created such clarity of purpose that millenials populating…